Abiopharma

Clinical trial NCT06545929 updates: 1. collaborators added: Imbrium Therapeutics 2. collaborators removed: Purdue Pharma LP

Clinical trial NCT04550442 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-03-31 → 2026-05-29 3. primary completion date: 2026-03-31 → 2026-05-29

Clinical trial NCT07079670 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-16 → 2026-05-11 3. primary completion date: 2026-04-16 → 2026-01-12

Clinical trial NCT07305805 updates: 1. status: RECRUITING → COMPLETED 2. start date: 2025-12-15 → 2025-12-16 3. completion date: 2026-05-21 → 2026-05-08 4. primary completion date: 2026-05-17 → 2026-04-21 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05421663: completion date: 2029-03-29 → 2041-07-30.

Clinical trial NCT05438043: completion date: 2029-01-31 → 2029-12-31.

Clinical trial NCT07258485 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-04-24 → 2026-06-04 3. enrollment: 80 → 94 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06570031: status: ACTIVE_NOT_RECRUITING → COMPLETED.

Clinical trial NCT07383506 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-02-01 → 2026-06-01

Clinical trial NCT07365735 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-19 3. primary completion date: 2026-05-01 → 2026-05-19 4. enrollment: 20 → 21 participants 5. enrollment type: ESTIMATED → ACTUAL